IIM
RGNX icon

INTECH Investment Management’s Regenxbio RGNX Stock Holding History

INTECH Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,435
Closed -$87.4K – 2250
2026
Q1 		$87.4K Sell
10,435
-10,932
-51% -$115K ﹤0.01% 1917
2025
Q4 		$308K Buy
21,367
+2,327
+12% +$29K ﹤0.01% 1749
2025
Q3 		$184K Sell
19,040
-8,060
-30% -$71.3K ﹤0.01% 2103
2025
Q2 		$222K Buy
27,100
+5,682
+27% +$47.6K ﹤0.01% 2034
2025
Q1 		$153K Buy
21,418
+1,944
+10% +$14.5K ﹤0.01% 2185
2024
Q4 		$151K Buy
19,474
+4,109
+27% +$38.6K ﹤0.01% 2114
2024
Q3 		$161K Buy
+15,365
New +$187K ﹤0.01% 1787

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

INTECH Investment Management's RGNX Position: Q2 2026 in Review

INTECH Investment Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 10,435 shares — an estimated $87.4K sold.

INTECH Investment Management first reported a position in RGNX in Q3 2024 and held it in 7 quarters. The position peaked at $308K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • INTECH Investment Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 10,435 Regenxbio shares in Q2 2026, an estimated $87.4K.
  • INTECH Investment Management first reported a position in Regenxbio in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Regenxbio position peaked at $308K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.